Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Anti-Adhesion Agent May Reduce Post-Surgical Infertility

By HospiMedica staff writers
Posted on 12 Nov 2007
A new study has found that a 4% Icodextrin solution was more effective in reducing the incidence of post-operative adhesions in patients undergoing gynecological laparoscopic adhesiolysis than lactated Ringer's solution (LRS). More...


Researchers at University of Sheffield (United Kingdom) and other institutions conducted a randomized, double-blinded trial that involved 402 patients who underwent gynecological laparoscopic surgery involving adhesiolysis at 16 sites in the United States. Two hundred and three patients were administered Adept adhesion reduction solution [4% Icodextrin Solution] during surgery and 199 patients were administered LRS. The Patients' primary diagnoses included pelvic pain, infertility, endometriosis, and known adhesions. A second follow-up laparoscopy was scheduled four to eight weeks later.

The results showed that among patients in the Adept group, more than 45% achieved clinical success--defined as the greater of a reduction in adhesions of at least three or 30% of sites lysed between the first and second laparoscopies--during the second physician observation compared to 35.6% in the LRS group. Among infertility patients, 52.9% of patients in the Adept group had a positive reduction in American Fertility Score (AFS), the standardized method to score and classify adhesions to the ovaries or fallopian tubes that may affect fertility, compared to 30.4% in the LRS group. The study was published in the November 2007 issue of Fertility and Sterility.

Adept adhesion reduction solution, a product of Vectura (Chippenham, UK), and Baxter International (Deerfield, Il, USA), is indicated for use intraperitoneally for the reduction of post-surgical adhesions in patients undergoing gynecological laparoscopic adhesiolysis. Adept is contraindicated in patients with known or suspected allergy to cornstarch based on polymers, such as icodextrin, with maltose or isomaltose intolerance, or with glycogen storage disease.

"Adhesions can take several days to form following surgery,” said Ron Lloyd, vice president of Baxter's biotherapeutics and regenerative medicine business. "Adept forms a fluid reservoir in the peritoneal cavity, that resides there during the critical period of adhesion formation, separating and minimizing contact between organs.”


Related Links:
University of Sheffield
Vectura
Baxter International

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Hybrid Arch Device
Neo EDE
New
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.